CAR-T cells targeting untransformed stromal cells, in particular CAFs, which promote the production of ECM components and growth factors (including TGF-β) and tumor progression, can suppress tumor growth and enhance host immunity without severe toxicity. Here, TGFB1 is linked to neoplasm.